Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -.--% | -.--% | -.--% |
2023 | Avivagen Inc. Announces New 500 Kg Order for OxC-beta | CI |
2023 | Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023 | CI |
Business Summary
Number of employees: 13
Sales per Business
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
OxC-Beta
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -27.53% |
Sales per region
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Philippines
83.8
%
| 1 | 77.7 % | 1 | 83.8 % | -21.93% |
Thailand
10.7
%
| 0 | 6.0 % | 0 | 10.7 % | +30.16% |
Mexico
-9.3
%
| 0 | 9.2 % | 0 | -9.3 % | -172.75% |
Taiwan
8.8
%
| 0 | 7.0 % | 0 | 8.8 % | -9.09% |
Brazil
6.0
%
| - | - | 0 | 6.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Graham W. Burton
FOU | Founder | - | 05-08-03 |
G. Anthony
CEO | Chief Executive Officer | 68 | 14-04-03 |
Ira Levy
DFI | Director of Finance/CFO | - | - |
James Nickerson
PSD | President | - | - |
David Hankinson
BRD | Director/Board Member | - | 05-08-03 |
Drew Basek
IRC | Investor Relations Contact | - | 17-02-28 |
Tracy Gillett
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Kraws
CHM | Chairman | 59 | 13-11-30 |
Aubrey Dan
BRD | Director/Board Member | - | 17-11-21 |
G. Anthony
CEO | Chief Executive Officer | 68 | 14-04-03 |
David Hankinson
BRD | Director/Board Member | - | 05-08-03 |
Paul Mesburis
BRD | Director/Board Member | 54 | 16-04-04 |
Graham W. Burton
FOU | Founder | - | 05-08-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 77,694,700 | 76,831,229 ( 98.89 %) | 0 | 98.89 % |
Company contact information
Sales per region
1st Jan change | Capi. | |
---|---|---|
-.--% | 284K | |
+11.33% | 11.43B | |
-0.75% | 5.77B | |
-4.08% | 4.87B | |
-5.10% | 4.14B | |
-23.66% | 2.58B | |
-5.06% | 1.75B | |
-24.53% | 1.11B | |
-18.46% | 865M | |
+24.67% | 855M |
- Stock Market
- Equities
- VIV Stock
- Company Avivagen Inc.